Abstract
It is important that providers are knowledgeable of the minor consent laws in their state regarding reproductive health care for adolescents and young adults, especially in regard to IUD provision. Providers should also have proficient knowledge of the risks and benefits of IUD placement to provide optimal pre- and post-procedural counseling for patients. As some adolescents or young adults have never had a pelvic exam, or may have experienced trauma in the past, it is imperative that providers approach these conversations in a sensitive, step-wise manner that optimizes patient education and comfort. This chapter will review how informed consent applies to adolescents and young adults, including those seeking IUD services, describe the risk and benefit profile of IUDs that should be included in the informed consent process, and offer sample language for how to provide pre-procedural, pelvic exam, and IUD insertion counseling for patients seeking IUD placement.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AYA:
-
Adolescents and Young Adult
- FDA:
-
Federal Drug Administration
- IUD:
-
Intrauterine Device
- LNG:
-
Levonorgestrel
- NSAID:
-
Non-Steroidal Anti-Inflammatory Drugs
- STI:
-
Sexually Transmitted Infection
References
English A. Sexual and reproductive health care for adolescents: legal rights and policy challenges. Adolesc Med State Art Rev. 2007;18:571–81, viii–ix.
Jones RK, Purcell A, Singh S, Finer LB. Adolescents’ reports of parental knowledge of adolescents’ use of sexual health services and their reactions to mandated parental notification for prescription contraception. JAMA. 2005;293:340–8.
Padon AA, Baren JM. Achieving a decision-making triad in adolescent sexual health care. Adolesc Med State Art Rev. 2011;22:183–94, vii.
An overview of minors’ consent law. In: Guttmacher Institute [Internet]. 14 Mar 2016 [cited 1 Dec 2018]. Available: https://www.guttmacher.org/state-policy/explore/overview-minors-consent-law.
Minors’ access to contraceptive services. In: Guttmacher Institute [Internet]. 14 Mar 2016 [cited 1 Dec 2018]. Available: https://www.guttmacher.org/state-policy/explore/minors-access-contraceptive-services.
Cason P, Goodman S. Protocol for provision of intrauterine contraception. San Francisco: UCSF Bixby Center Beyond the Pill. 2016 [Internet]. [cited 1 Dec 2018]. Available: https://beyondthepill.ucsf.edu/sites/beyondthepill.ucsf.edu/files/Beyond%20the%20Pill%20IUC%20Protocol.pdf.
Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception. 1997;56:341–352.
McNicholas C, Swor E, Wan L, Peipert JF. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration. Am J Obstet Gynecol. 2017;216:586.e1–6.
Mirena (levonorgestrel-releasing intrauterine system). Highlights of prescribing information [Internet]. [cited 1 Dec 2018]. Available: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021225s027lbl.pdf.
Kyleena (levonorgestrel-releasing intrauterine system). Highlights of prescribing information [Internet]. [cited 1 Dec 2018]. Available: https://labeling.bayerhealthcare.com/html/products/pi/Kyleena_PI.pdf.
Skyla (levonorgestrel-releasing intrauterine system). Highlights of prescribing information [Internet]. [cited 1 Dec 2018]. Available: http://labeling.bayerhealthcare.com/html/products/pi/Skyla_PI.pdf.
Daniele MAS, Cleland J, Benova L, Ali M. Provider and lay perspectives on intra-uterine contraception: a global review. Reprod Health. 2017;14:119.
Sufrin CB, Postlethwaite D, Armstrong MA, Merchant M, Wendt JM, Steinauer JE. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease. Obstet Gynecol. 2012;120:1314–21.
Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet. 1992;339:785–8.
Jatlaoui TC, Riley HEM, Curtis KM. The safety of intrauterine devices among young women: a systematic review. Contraception. 2017;95:17–39.
Li C, Zhao W-H, Zhu Q, Cao S-J, Ping H, Xi X, et al. Risk factors for ectopic pregnancy: a multi-center case-control study. BMC Pregnancy Childbirth. 2015;15:187.
Rossing MA, Daling JR, Voigt LF, Stergachis AS, Weiss NS. Current use of an intrauterine device and risk of tubal pregnancy. Epidemiology. 1993;4:252–8.
IUD insertion consent form. In: Reproductive health access project [Internet]. [cited 1 Dec 2018]. Available: https://www.reproductiveaccess.org/wp-content/uploads/2013/02/iud_consent.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Greenberg, K.B. (2019). Consenting and Pre-procedural Counseling for IUD Insertion: What to Expect and What to Talk About. In: Coles, M., Mays, A. (eds) Optimizing IUD Delivery for Adolescents and Young Adults. Springer, Cham. https://doi.org/10.1007/978-3-030-17816-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-17816-1_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17815-4
Online ISBN: 978-3-030-17816-1
eBook Packages: MedicineMedicine (R0)